Sensitive and specific determination of midazolam and 1-hydroxymidazolam in human serum by liquid chromatography–electrospray mass spectrometry
- 20 October 1999
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 734 (1) , 137-144
- https://doi.org/10.1016/s0378-4347(99)00340-0
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Sensitive assay for midazolam and its metabolite 1′-hydroxymidazolam in human plasma by capillary high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- What changes drug metabolism in critically ill patients‐III? Effect of pre‐existing disease on the metabolism of midazolamAnaesthesia, 1996
- Measurement by HPLC of Midazolam and its Major Metabolite 1-Hydroxymidazolam in Plasma of Very Premature NeonatesBiomedical Chromatography, 1996
- Determination of midazolam and its unconjugated 1-hydroxy metabolite in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Prolonged sedation due to accumulation of conjugated metabolites of midazolamThe Lancet, 1995
- Automated determination of midazolam in human plasma by high-performance liquid chromatography using column switchingJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Determination of Midazolam and Its α-Hydroxy Metabolite in Human Plasma and Urine by High-Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1993
- A three-step approach combining bayesian regression and NONMEM population analysis: Application to midazolamJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Quantification of the EEG Effect of Midazolam by Aperiodic Analysis in VolunteersClinical Pharmacokinetics, 1990
- Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous systemClinical Pharmacology & Therapeutics, 1988